Assessing the Role of Inflammatory Markers in Predicting Central Lymph Node Metastasis in Papillary Thyroid Carcinoma

Document Type : Original

Authors

1 Department of Otorhinolaryngology-Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran , Department of Cardiothoracic Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.

2 Department of Otorhinolaryngology-Head and Neck Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.

3 Department of Pediatric Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.

4 Department of Cardiothoracic Surgery, Tabriz University of Medical Sciences, Tabriz, Iran.

10.22038/ijorl.2025.84332.3840

Abstract

The current study sought to assess the predictive value of inflammatory markers, namely the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR), in relation to central lymph node metastasis (CLNM) in patients with papillary thyroid carcinoma (PTC). 
Materials and Methods:
A total of 79 participants with confirmed PTC diagnosis following surgery were included in the study. Demographic data, clinical characteristics, and laboratory variables were collected. CLNM was evaluated based on pathological findings. NLR and PLR were calculated to assess their associations with clinicopathological features and metastasis.
Results:
The study included 26 males (25.9%) and 53 females (74.1%), with a mean age of 42.26 years (range 15–74). Significant findings included a higher incidence of CLNM in males (p=0.047) and larger tumor sizes in patients with CLNM (p=0.047). Tumor multifocality was also more common in the CLNM group (62.5% vs. 28.9%, p=0.003). Although no significant relationship was found between the inflammatory markers NLR, PLR, and CLNM, a meaningful association was observed between PLR and age in patients with CLNM (r= 0.414, p=0.011).
Conclusion:
This study demonstrates significant associations between clinicopathological features and CLNM in PTC. Male gender, larger tumor size, and multifocality correlated with higher CLNM rates. While inflammatory markers such as NLR and PLR did not show significant differences, PLR's positive correlation with age in CLNM patients suggests potential prognostic value, warranting further investigation. 

Keywords

Main Subjects

References

  1. Tay S-Y, Chen C-Y, Chan WP. Sonographic criteria predictive of benign thyroid nodules useful in avoiding unnecessary ultrasound-guided fine needle aspiration. Journal of the Formosan Medical Association. 2015;114(7):590-7.
  2. Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid : official journal of the American Thyroid Association. 2000;10(8):709-12.
  3. Pacini F, Burroni L, Ciuoli C, Di Cairano G, Guarino E. Management of thyroid nodules: a clinicopathological, evidence-based approach. European Journal of Nuclear Medicine and Molecular Imaging. 2004;31:1443-9.
  4. Gulcelik NE, Gulcelik MA, Kuru B. Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Archives of Otolaryngology–Head & Neck Surgery. 2008;134(12):1312-5.
  5. Baloch ZW, LiVolsi VA, Asa SL, Rosai J, Merino MJ, Randolph G, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference. Diagnostic cytopathology. 2008;36(6):425-37.
  6. Whiteside T. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27(45):5904-12.
  7. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. nature. 2008; 454(7203): 436-44.
  8. Li X, Ma X, Tang L, Wang B, Chen L, Zhang F, et al. Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis. Oncotarget. 2017;8(37):62681.
  9. Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. International Journal of Molecular Sciences. 2019;20(18):4413.
  10. Kuzu F, Arpaci D, Cakmak GK, Emre AU, Unal M, Bahadir B, et al. The value of blood cell markers in patients with thyroid nodules including atypia of undetermined significance/follicular lesion of undetermined significance cytology. Medicine. 2018;7(2):386-90.
  11. Proctor M, McMillan D, Morrison D, Fletcher C, Horgan P, Clarke S. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. British journal of cancer. 2012;107(4):695-9.
  12. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer. Critical reviews in oncology/hematology. 2013;88(1):218-30.
  13. Tan D, Fu Y, Su Q, Wang H. Prognostic role of platelet–lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Medicine. 2016;95(24).
  14. Farashi E, Rasihashemi SZ, Shilan Z, Farashi Bonab S. Outcomes and Pathological Features of Total Thyroidectomy in Patients with Multifocal Papillary Thyroid Carcinoma. Duzce Medical Journal. 2023;25(1):50-5.
  15. Feng J-W, Qu Z, Qin A-C, Pan H, Ye J, Jiang Y. Significance of multifocality in papillary thyroid carcinoma. European Journal of Surgical Oncology. 2020;46(10):1820-8.
  16. Zhang T, He L, Wang Z, Dong W, Sun W, Zhang P, et al. Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer. Frontiers in Oncology. 2022;12:1003336.
  17. Liu CL, Lee JJ, Liu TP, Chang YC, Hsu YC, Cheng SP. Blood neutrophil‐to‐lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. Journal of surgical oncology. 2013;107(5):493-7.
  18. Manatakis DK, Tseleni-Balafouta S, Balalis D, Soulou VN, Korkolis DP, Sakorafas GH, et al. Association of baseline neutrophil‐to‐lymphocyte ratio with clinicopathological characteristics of papillary thyroid carcinoma. International journal of endocrinology. 2017;2017(1):8471235.
  19. Feng J, Wang Y, Shan G, Gao L. Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer: A meta-analysis. Medicine. 2020;99(20):e19686.
  20. Özdemir A, Bandırmalı O. Is there a predictive value of systemic inflammatory parameters and prognostic nutritional index in the detection of lymphatic metastases in papillary thyroid cancers? Journal of Experimental and Clinical Medicine. 2024; 41(1):14-9.
  21. Chen Y, Wu F, Ge M, Hu T, Qian S, Cai Y, et al. A Retrospective Analysis: A Predictive Model Using Platelets and Neutrophil-to-Lymphocyte Ratio for the Number of Lymph Node Metastasis in Papillary Thyroid Carcinoma. 2024.
  22. Lang BH-H, Ng CP-C, Au KB, Wong KP, Wong KK, Wan KY. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma? World journal of surgery. 2014; 38: 2605-12.
  23. Cao J, He X, Li X, Sun Y, Zhang W, Li Y, et al. The potential association of peripheral inflammatory biomarkers in patients with papillary thyroid cancer before radioiodine therapy to clinical outcomes. Frontiers in Endocrinology. 2023;14:1253394.
  24. Wang X, Liu W, Zhao M. Correlation between preoperative platelet parameters and clinicopathological features of differentiated thyroid cancer. Lin Chuang er bi yan hou tou Jing wai ke za zhi= Journal of Clinical Otorhinolaryngology, Head, and Neck Surgery. 2023;37(10):796-800.
  25. Ari A, Gunver F. Comparison of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in patients with thyroiditis and papillary tumors. Journal of International Medical Research. 2019; 47(5): 2077-83.
  26. Zhao L, Zhou T, Zhang W, Wu F, Jiang K, Lin B, et al. Blood immune indexes can predict lateral lymph node metastasis of thyroid papillary carcinoma. Frontiers in Endocrinology. 2022;13:995630.
  27. Fugazzola L, Muzza M, Pogliaghi G, Vitale M. Intratumoral genetic heterogeneity in papillary thyroid cancer: occurrence and clinical significance. Cancers. 2020;12(2):383.
  28. Xie H, Wei B, Shen H, Gao Y, Wang L, Liu H. BRAF mutation in papillary thyroid carcinoma (PTC) and its association with clinicopathological features and systemic inflammation response index (SIRI). American Journal of Translational Research. 2018;10(8):2726.
  29. Pagano L, Mele C, Sama MT, Zavattaro M, Caputo M, De Marchi L, et al. Thyroid cancer phenotypes in relation to inflammation and autoimmunity. Frontiers in bioscience. 2018;23(12):2267-82.
  30. Korniluk A, Koper-Lenkiewicz OM, Kamińska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions. Mediators of inflammation. 2019;2019.
  31. Pujani M, Chauhan V, Singh K, Rastogi S, Agarwal C, Gera K. The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio. Hematology, Transfusion and Cell Therapy. 2021;43:424-9.
  32. Shilpi K, Potekar R. A study of platelet indices in type 2 diabetes mellitus patients. Indian Journal of Hematology and Blood Transfusion. 2018; 34: 115-20.

 

 

 

 

Iranian Journal of Otorhinolaryngology
Volume 37, Issue 3
May and June 2025
Pages 135-141

Files

Share

How to cite

Statistics